‘Important implications for policies that restrict access to travel or venues or require vaccination’

WND News Center

Having had COVID-19 provides just as much protection as the experimental vaccinations highly promoted by the U.S. government, including Anthony Fauci, who used to run the infectious diseases division of the National Institutes of Health.

Fox News explained the results were published in the Lancet on Feb. 16.

It said the study found “a previous COVID-19 infection offers at least the same level of protection as two doses of high-quality mRNA vaccines, such as Moderna and Pfizer-BioNTech. Additionally, people who are infected with the virus may be protected from reinfection for 40 weeks or longer, the study found.”

The report explained the study noted protection against reinfection was highest for the original strain of COVID, as well as the alpha, beat and delta variants, “remaining at more than 78% after 40 weeks.”

Fox reported the study showed the level of protection does decline over time for all variants.

The study was called “Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.”

Researchers who make up a forecasting team for COVID-19 released the assessment.

Dr. Marc Siegel, professor of medicine at NYU Langone Medical Center, told Fox immunity from prior infection, natural immunity, and immunity from vaccines both provide significant protection against severe illness and some protection (for at least a few months) against getting the virus again.

He explained, “This is the reason that I don’t generally recommend the vaccine booster for at least a few months following infection.”

Fox explained, “The new study’s findings could call into question vaccine requirement policies.”

The study itself explained, “This finding also has important implications for the design of policies that restrict access to travel or venues or require vaccination for workers. It supports the idea that those with a documented infection should be treated similarly to those who have been fully vaccinated with high-quality vaccines.”

The conclusion comes after the researchers looked at 65 studies from 19 different nations, comparing those who had recovered from COVID to those who had not been infected.